Call Extraction: CDL Review MedScout Strategies — Pre-Training Pressure Test

DDX ID: 1075 Date: 2025-11-17 Duration: ~64 minutes Participants: Phil Cranmer (CDL), Kathryn White (MedScout CSM), Meaghan DePeter (MedScout, observer/transition). Call type: Strategy review and pressure testing session. Phil walking through all configured strategies before team training, testing workflows, and deciding whether hospital team gets trained this week or delayed to January. Triage: Rich. Longest call in this batch. Multiple distinct fingerprint insights: the 50/50 hospital rollout decision, the discovery-vs-strategy mental model tension, referral pathway selectivity by modality, IDTF as a distinct targeting category, mobile units as competitive intelligence, and Phil’s training design approach.

Distinct Insights

1. Phil is 50/50 on hospital team rollout — willing to delay rather than damage credibility

What: Phil: “I’m not going to lie to you guys. Part of me wants to delay the hospital training. I’m not there yet, but it’s not ready for them.” And: “I’m honestly 50/50 whether or not we roll this out to hospital yet.” He specifically predicted Lynette’s reaction: “I know Lynette’s going to shit all over me. She just is, I know it. That map’s going to screw her up. She’s going to hate it.”

So what: Phil protects his internal credibility by controlling what his team sees and when. He won’t expose the hospital team (led by Lynette, who has high standards and low tolerance for friction) to a tool that has dead-end workflows, because a bad first impression creates adoption resistance that’s harder to overcome than a delayed launch. His calculation: the risk of Lynette rejecting the tool after a frustrating first experience outweighs the cost of waiting until January when account-level data visibility will be live. This reveals something about CDL’s internal dynamics — Lynette’s reaction to tools shapes hospital team adoption, and Phil manages that gatekeeping deliberately. He’s not worried about the private practice team (simpler use case, more tolerant users), but the hospital team has both higher expectations and more complex requirements.

Speaker credibility: Phil, making a real-time strategic decision about his own team. Very high. Scope: Health system motion rollout timing. Motion: Hospital team directly; indirectly affects overall CDL adoption trajectory.

2. Referral intelligence is valuable for cardiac but not oncology — modality-specific selectivity

What: When asked about inbound referral pathways: Phil wanted them for SPECT (yes), cardiac PET (yes), CCTA (yes — “both” cardiac PET and CCTA referrals), but oncology PET (definitively “no”).

So what: CDL views referral intelligence differently by clinical pathway. For cardiac procedures (SPECT, cardiac PET, CCTA), understanding who refers patients matters because those referring physicians are potential relationship targets — a cardiologist sending patients for SPECT could be convinced to advocate for cardiac PET, and the PCP referring patients for CCTA is already in a cardiac workflow that could expand to PET. But for oncology PET, the referral dynamics are different. Oncologists refer for PET staging as part of cancer care protocols, not as a discretionary imaging choice. CDL can’t influence oncology referral patterns the way they can influence cardiac referral patterns, because oncology PET ordering follows clinical guidelines rather than physician preference. CDL’s interest in oncology PET is purely as an infrastructure indicator (camera on-site = CardioNavix play), not as a referral relationship opportunity. Understanding referrals around oncology PET wouldn’t change CDL’s approach to that account.

Speaker credibility: Phil, defining which data views his team needs. High — this is a deliberate choice, not oversight. Scope: Both motions — the modality distinction applies universally. Motion: Both.

3. IDTF (Independent Diagnostic Testing Facility) is a distinct targeting category for CDL

What: Phil asked: “How did you get it down to IDTFs?” and Kathryn explained it’s based on place of service codes — independent clinics, labs, mobile units. Phil approved: “No, that’s fine. Leave that.”

So what: CDL targets three distinct facility types: hospitals (multi-stakeholder sale, Lynette’s team), private practices (physician-is-the-decision-maker, Rob’s team), and IDTFs (independent imaging centers). IDTFs are neither hospital nor private practice — they’re standalone imaging facilities that could be independently owned, part of a chain, or operated by a competitor. The IDTF category matters for CDL because these facilities already have imaging infrastructure and volume, but their ownership and decision-making structure is different from both hospitals and practices. An IDTF doing high-volume SPECT but no cardiac PET is a conversion target, but the sales approach differs — the decision maker might be an imaging center operator/entrepreneur rather than a physician or hospital administrator. CDL has this as a separate strategy (strategy #7), which means they’ve identified enough IDTFs to warrant a dedicated targeting approach rather than lumping them in with private practice or hospital.

Speaker credibility: Phil confirming the IDTF strategy as valid. Kathryn explaining the data logic. Scope: Both motions could encounter IDTFs, but this is likely closest to private practice motion’s territory. Motion: Primarily private practice (similar decision-maker structure), but distinct enough to warrant its own category.

4. Mobile unit tracking as competitive intelligence — competitors’ footprint visible in claims

What: Kathryn referenced a prior conversation where the team got excited about seeing claims associated with mobile imaging units, which revealed competitor activity. Phil deferred to the hospital team for requirements but confirmed it’s not part of minimum viable product.

So what: CDL’s competitors also operate mobile nuclear imaging units — they bring SPECT cameras to hospitals that don’t have permanent installations. When those mobile units bill claims, the claims data captures the mobile unit’s place of service designation. CDL can use this to map where competitors are operating mobile units across the country. This is valuable competitive intelligence: a hospital using a competitor’s mobile SPECT unit is (a) already doing SPECT and therefore has patient demand, (b) hasn’t committed to a permanent installation (otherwise they wouldn’t need mobile), and (c) has a vendor relationship that CDL could potentially displace. The mobile unit signal in claims data reveals competitor footprint without CDL needing any competitive intelligence tools — the claims themselves carry the signal. Phil’s deferral (“when we roll this out to the hospital team”) suggests this is primarily a hospital team play, likely because hospitals are the typical users of mobile imaging services.

Speaker credibility: Kathryn reporting team enthusiasm from a prior call. Phil confirming it’s real but deprioritizing for now. Scope: Primarily hospital motion — mobile imaging is more common in hospital settings. Motion: Hospital team.

5. Phil designs training as a narrowing funnel — discovery to strategies to drill-down

What: Phil outlined the training flow: “We can start with discovery and just say this is everything wide open… However, we’ve applied criteria if you want criteria applied for better more precise targeting… Now, we’re going to go through a use case… You’re going to put in your geography, you’re going to select your strategy, select your geography, and you’re going to get your accounts.” And later: “Discovery, strategies, more precise targeting, hospital account identification, provider identification, payer mix, payment rate, referral pathways.”

So what: Phil frames the data tool as a narrowing funnel for his team, not as a feature set. He starts with the total addressable market (discovery = everything), then narrows through filters (strategies = criteria applied), then narrows further to specific accounts and providers. This framing matters because it shapes how CDL reps think about targeting. They start with “what’s the universe?” and systematically narrow to “who should I call?” Phil’s approach also reveals his sales philosophy: reps should understand the total market before focusing on filtered targets, so they appreciate why the filter matters and can articulate the opportunity size to prospects (“there are 151 sites in Orlando doing nuclear cardiology, but we’ve identified the top 27 for you”). He’s not just training tool usage — he’s training a targeting methodology that the tool enables.

Speaker credibility: Phil, designing training for his own team. He said: “I’ve rolled out a few of these before.” High. Scope: Company-wide training approach. Motion: Both — though he acknowledged he’d co-moderate, adapting the flow per audience.

6. Account attribution: place-of-service codes are imperfect but “good enough”

What: Phil questioned an Orlando medical center appearing in private practice results. Kathryn explained it’s driven by place of service on claims. Phil tested Piedmont Heart Institute — correctly excluded from private practice. His assessment: acceptable for now, not perfect.

So what: CDL routes opportunities to different sales teams based on facility type — private practice goes to Rob’s team, hospital goes to Lynette’s team. The routing depends on accurate classification. Claims data uses place of service codes (office, outpatient, inpatient, mobile, etc.) to determine facility type, but this isn’t always clean — a health system’s outpatient clinic might bill as “office” and appear as private practice. CDL has already invested effort (with Ronnie and Daniel) in building attribution logic. Phil’s acceptance of edge cases (“I’m guessing that’s being flagged as a hospital” — confirmed correct) suggests the attribution is working for the vast majority of accounts. The remaining misclassifications aren’t blocking progress. This is relevant to CDL’s fingerprint because it shows they pragmatically accept “good enough” data classification rather than demanding perfection — as long as the big accounts route correctly, edge cases can be handled manually.

Speaker credibility: Phil testing the system against his market knowledge, Kathryn explaining the methodology. Both high. Scope: Both motions — affects opportunity routing to correct teams. Motion: Both.

Transcription Notes

“Spec” — Phil frequently says “spec” for SPECT throughout. This is his natural shorthand, not a transcription error.
“Catherine” — Kathryn White, consistent with all other calls.
Doug and Todd — BDMs covering East Florida and Georgia respectively. These names are consistent with other transcripts.
Meaghan DePeter — present as observer during Kathryn-to-Meaghan transition. First appearance in a call with Phil.
“Ronnie and Daniel” — referenced as having worked on account attribution logic during initial implementation. “Ronnie” is Ronald Miller from call 0461.
“Skyler” — referenced (not present) regarding the January 2 delivery commitment. Consistent spelling variation of Skylar Talley across transcripts.
Rolling 12-month timeframe — Kathryn noted: “Unfortunately at this moment in time, we don’t have that rolling 12 month capability.” Flagged as repeated feedback. CDL currently uses fixed 2024-2025 timeframe.
No new term bank entries needed from this call.